The Image-Guided Radiation Therapy Market Forecast shows significant growth due to advancements in healthcare infrastructure, increasing cancer prevalence, and favorable reimbursement policies. Key technological innovations, regulatory frameworks, and the rising adoption of minimally invasive procedures further support market expansion, although competition from alternative treatments like IMRT could constrain growth.
The report Image-Guided Radiation
Therapy Market is projected to reach USD 2.4 billion by 2028 from
USD 1.9 billion in 2023, growing at a CAGR of 5.2% during the forecast period.
Download PDF
Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171554723
Market Segmentation: -
PET/ MRI-guided radiation therapy segment to
register a significant growth rate over the forecast period of 2022-2028.
Based on the product, the image-guided radiation therapy market
is segmented into LINAC (linear accelerator), 4D gating/ 4D RT, PET/ MRI-guided
radiation therapy, CT scanning, and portal imaging. The capability of PET/MRI
to furnish functional insights directs the administration of radiation doses,
effectively mitigating healthy tissue exposure and subsequently alleviating the
occurrence of adverse effects. This contribution significantly bolsters the
market trajectory of image-guided radiation therapy, enhancing its appeal and
positioning within the healthcare landscape.
The breast cancer application segment accounted for
a significant share of the image-guided radiation therapy market in 2022-2028.
Based on the application, the image-guided radiation therapy
market is segmented into breast cancer, prostate cancer, head & neck
cancer, lung cancer, gastrointestinal cancer, gynecological cancer, and other
applications. The rising incidence of cancer worldwide is a significant driver
for the image-guided radiation therapy market. The precision inherent in
image-guided radiation therapy (IGRT) mitigates the necessity for frequent and
discomforting repositioning of patients during treatment sessions.
Intensity modulation radiation therapy procedure
segment accounted for the largest share of the image-guided radiation therapy
market in 2022-2028.
Based on the procedure, the image-guided radiation therapy
market is segmented into 3D conformal therapy, stereotactic therapy, proton
beam therapy, intensity modulation radiation therapy, and particle
therapy. The intensity modulation radiation therapy procedure segment is
estimated to hold the 39.2% market share of the image-guided radiation
therapy market in 2022. Intensity Modulated Radiation Therapy (IMRT) is
instrumental in crafting tailored treatment blueprints through the optimization
of radiation administration based on tumor dimensions, contours, and placement.
This congruence aligns seamlessly with the personalized treatment ethos central
to Image-Guided Radiation Therapy (IGRT).
Hospitals segment to register for the largest market
share of the image-guided radiation therapy market in 2022-2028.
The major end users in the image-guided radiation therapy market
are independent radiotherapy centers and hospitals. Hospitals are expected to
account for a major market share in 2022. Healthcare institutions grapple with
a considerable influx of cancer patients, thereby magnifying the attraction
towards image-guided radiation therapy (IGRT). The precision inherent in IGRT's
tumor-targeting proficiency and its streamlined treatment delivery harmonize
seamlessly with the necessity of proficiently managing the patient caseload.
Regional Analysis:-
In 2022, the North American region is expected to register
significant growth in the market during the forecast period. North America
comprises the US and Canada. North America has an advanced healthcare
infrastructure, which is associated with a higher incidence of cancer. In North
America, a highly developed healthcare infrastructure coupled with ready access
to state-of-the-art medical technologies creates a conducive environment for
the assimilation of progressive treatment modalities, such as image-guided
radiation therapy (IGRT).
Key Players:-
As of 2022, prominent players in the image-guided radiation
therapy market are Siemens Healthineers AG (Germany), Elekta (Sweden), and
Accuray Incorporated (US), among others.
Recent
developments
Recent developments, such as
Philips' Zenition 10, GE HealthCare's advances in PET/MR capabilities, and the
launch of Pixxoscan, highlight the industry's commitment to advancing cancer
care.
Conclusion
Image-Guided Radiation
Therapy is revolutionizing cancer treatment by offering precise,
patient-centric care. As a medical industry expert, I'm thrilled to witness
this transformation. With continued advancements, a supportive healthcare
ecosystem, and a global focus on non-invasive cancer interventions, IGRT is set
to play a pivotal role in shaping the future of cancer treatment worldwide. As
the industry embraces innovation, research, and collaboration, the promise of
improved cancer outcomes becomes increasingly achievable.
Content Source:
-
Image-Guided
Radiation Therapy Market Report
No comments:
Post a Comment